{"id":"https://openalex.org/W2108087296","doi":"https://doi.org/10.1016/j.jalz.2014.05.605","title":"P1\u2010363: MONITORING THE SOLUBLE AMYLOID PRECURSOR PROTEIN ALPHA (SAPPA) AND BETA (SAPPB) FRAGMENTS IN PLASMA AND CSF FROM HEALTHY INDIVIDUALS TREATED WITH BACE INHIBITOR AZD3293 IN A MULTIPLE ASCENDING DOSE STUDY: PHARMACOKINETIC AND PHARMACODYNAMIC CORRELATE","display_name":"P1\u2010363: MONITORING THE SOLUBLE AMYLOID PRECURSOR PROTEIN ALPHA (SAPPA) AND BETA (SAPPB) FRAGMENTS IN PLASMA AND CSF FROM HEALTHY INDIVIDUALS TREATED WITH BACE INHIBITOR AZD3293 IN A MULTIPLE ASCENDING DOSE STUDY: PHARMACOKINETIC AND PHARMACODYNAMIC CORRELATE","alternate_titles":[],"publication_year":2014,"publication_date":"2014-07-01","ids":{"openalex":"https://openalex.org/W2108087296","doi":"https://doi.org/10.1016/j.jalz.2014.05.605","mag":"2108087296"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2014.05.605","doi":"https://doi.org/10.1016/j.jalz.2014.05.605","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jalz.2014.05.605","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2014.05.605","source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2108087296"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2014.05.605","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055898700","display_name":"Kina H\u00f6glund","orcid":"https://orcid.org/0000-0002-1213-9953","observed_orcids":["https://orcid.org/0000-0002-1213-9953"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Kina H\u00f6glund","raw_affiliation_strings":["AstraZeneca, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Stockholm, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040065277","display_name":"Hugh Salter","orcid":"https://orcid.org/0000-0001-5705-2950","observed_orcids":["https://orcid.org/0000-0001-5705-2950"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hugh Salter","raw_affiliation_strings":["AstraZeneca, Solna, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Solna, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079766290","display_name":"Henrik Zetterberg","orcid":"https://orcid.org/0000-0003-3930-4354","observed_orcids":["https://orcid.org/0000-0003-3930-4354"]},"institutions":[{"id":"https://openalex.org/I881427289","display_name":"University of Gothenburg","ror":"https://ror.org/01tm6cn81","country_code":"SE","type":"education","lineage":["https://openalex.org/I881427289"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Henrik Zetterberg","raw_affiliation_strings":["Sahlgrenska Academy, University of Gothenburg M\u00f6lndal Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sahlgrenska Academy, University of Gothenburg M\u00f6lndal Sweden","institution_ids":["https://openalex.org/I881427289"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057473716","display_name":"Ulf Andr\u00e9asson","orcid":"https://orcid.org/0000-0001-8622-052X","observed_orcids":["https://orcid.org/0000-0001-8622-052X"]},"institutions":[{"id":"https://openalex.org/I881427289","display_name":"University of Gothenburg","ror":"https://ror.org/01tm6cn81","country_code":"SE","type":"education","lineage":["https://openalex.org/I881427289"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ulf Andreason","raw_affiliation_strings":["Sahlgrenska Academy, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sahlgrenska Academy, Gothenburg, Sweden","institution_ids":["https://openalex.org/I881427289"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104074178","display_name":"Tina Olsson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tina Olsson","raw_affiliation_strings":["AstraZeneca, Cambridge, Massachusetts, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Cambridge, Massachusetts, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103079586","display_name":"Robert Alexander","orcid":"https://orcid.org/0000-0002-6889-2952","observed_orcids":["https://orcid.org/0000-0002-6889-2952"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert Alexander","raw_affiliation_strings":["AstraZeneca, Cambridge, Massachusetts, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Cambridge, Massachusetts, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091559601","display_name":"Alan R. Kugler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alan Kugler","raw_affiliation_strings":["AstraZeneca, Cambridge, Massachusetts, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Cambridge, Massachusetts, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063415568","display_name":"Gvido Cebers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gvido Cebers","raw_affiliation_strings":["AstraZeneca, Cambridge, Massachusetts, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Cambridge, Massachusetts, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065200734","display_name":"Naidong Ye","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Naidong Ye","raw_affiliation_strings":["AstraZeneca, Cambridge, Massachusetts, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Cambridge, Massachusetts, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103916061","display_name":"Doug Burdette","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Doug Burdette","raw_affiliation_strings":["AstraZeneca, Cambridge, Massachusetts, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Cambridge, Massachusetts, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113694508","display_name":"Samantha L. Budd Haeberlein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Samantha L. Budd Haeberlein","raw_affiliation_strings":["AstraZeneca R&D Cambridge Massachusetts United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D Cambridge Massachusetts United States","institution_ids":["https://openalex.org/I4210150756"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5055898700"],"corresponding_institution_ids":["https://openalex.org/I4210143795"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":1.0616,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.6901037,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"10","issue":"4S_Part_11","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sappalpha","display_name":"sAPP\u03b1","score":0.7379999756813049}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5871949791908264},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5337321162223816},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4812695384025574},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.4614796042442322},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.45169708132743835},{"id":"https://openalex.org/C31705614","wikidata":"https://www.wikidata.org/wiki/Q423510","display_name":"Amyloid precursor protein","level":4,"score":0.4413031041622162},{"id":"https://openalex.org/C2776156579","wikidata":"https://www.wikidata.org/wiki/Q417667","display_name":"Amyloid beta","level":3,"score":0.4292919635772705},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3910320997238159},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.3690456748008728},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3669472336769104},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3407527208328247},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29520654678344727},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.27028173208236694},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.14744257926940918},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.07406258583068848},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2014.05.605","doi":"https://doi.org/10.1016/j.jalz.2014.05.605","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jalz.2014.05.605","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2014.05.605","source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jalz.2014.05.605","doi":"https://doi.org/10.1016/j.jalz.2014.05.605","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jalz.2014.05.605","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2014.05.605","source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2108087296.pdf","grobid_xml":"https://content.openalex.org/works/W2108087296.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2539016063","https://openalex.org/W2532056566","https://openalex.org/W2536505568","https://openalex.org/W2083437219","https://openalex.org/W2258663952","https://openalex.org/W2037357350","https://openalex.org/W1512916808","https://openalex.org/W4255963906","https://openalex.org/W2060598171","https://openalex.org/W2052830338"],"abstract_inverted_index":{"BACE1":[0,92,235,267],"catalyzes":[1],"sAPP":[2,73,83,138,239],"cleavage":[3],"during":[4,55,121],"\u03b2":[5,141,240],"-amyloid":[6],"(A":[7],"\u03b2)":[8],"peptide":[9],"production":[10],"and":[11,23,37,50,85,102,112,120,131,136,140,162,198,229,242],"is":[12],"a":[13,56,78,191,204],"key":[14],"therapeutic":[15],"opportunity":[16],"in":[17,61,94,106,114,158,262,266],"AD.":[18],"Biomarkers":[19],"of":[20,25,31,40,82,87,129,160,166,187,225,227,234,253],"target":[21],"engagement":[22],"mechanism":[24,224],"action":[26,226],"can":[27],"yield":[28],"early":[29],"indications":[30],"efficacy,":[32],"help":[33],"set":[34],"clinical":[35],"doses":[36],"characterize":[38],"PK/PD":[39,152,264],"candidate":[41],"drugs.":[42],"Clinical":[43],"data":[44,142,149,175],"for":[45,210],"soluble":[46],"fragments":[47,105],"alpha":[48,100],"(sAPP\u03b1)":[49,101],"beta":[51,103],"(sAPP\u03b2)":[52,104],"were":[53,109,117,143,168,176],"collected":[54],"Multiple":[57],"Ascending":[58],"Dose":[59],"study":[60],"elderly":[62],"Healthy":[63],"Volunteers,":[64],"with":[65,178,221],"the":[66,184,188,222,246],"BACE":[67],"inhibitor":[68],"AZD3293.":[69],"Based":[70],"upon":[71],"known":[72],"metabolism,":[74],"we":[75],"hypothesized":[76,223],"that":[77,231],"dose":[79,181],"dependent":[80],"decrease":[81,157],"\u03b2,":[84],"increase":[86,165],"sAPP\u03b1,":[88,167],"would":[89],"result":[90],"from":[91],"inhibition":[93,200,233],"this":[95],"study.":[96],"Methods":[97],"to":[98,145,150,207,237],"quantitate":[99],"human":[107],"matrices":[108],"developed.":[110],"CSF":[111,124,137,159],"plasma":[113],"healthy":[115],"volunteers":[116],"sampled":[118],"pre-treatment":[119],"24h":[122],"continuous":[123],"sampling":[125],"after":[126],"14":[127],"days":[128],"15":[130],"50":[132],"mg":[133],"dosing.":[134],"Plasma":[135],"\u03b1":[139],"compared":[144],"corresponding":[146],"AZD3293":[147,195,228],"concentration":[148,196],"assess":[151],"correlations.":[153],"A":[154,211],"dose-dependent":[155,164],"sustained":[156,232],"sAPP\u03b2,":[161],"broadly":[163],"observed.":[169],"While":[170],"sAPP\u03b1":[171],"levels":[172,241],"generally":[173],"increased,":[174],"variable":[177],"no":[179],"apparent":[180],"dependency.":[182],"Within":[183],"linear":[185],"range":[186],"sAPP\u03b2":[189,199],"assay,":[190],"direct":[192],"correlation":[193],"between":[194],"(Cmax)":[197],"was":[201],"observed":[202],"on":[203],"similar":[205],"timeline":[206],"effects":[208],"seen":[209],"\u03b24":[212],"0/42":[213],"(data":[214],"not":[215],"shown).":[216],"The":[217],"observations":[218],"are":[219],"consistent":[220],"indicate":[230],"leads":[236],"reduced":[238],"increased":[243],"flux":[244],"through":[245],"non-pathogenic":[247],"\u03b1-":[248],"secretase-mediated":[249],"pathway.":[250],"Therefore,":[251],"measures":[252],"amyloid":[254],"metabolism":[255],"other":[256],"than":[257],"A\u03b242/40":[258],"have":[259],"significant":[260],"utility":[261],"determining":[263],"relationships":[265],"inhibition.":[268]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2108087296","counts_by_year":[{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
